Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

Trial ID or NCT#

NCT01135355

Status

not recruiting iconNOT RECRUITING

Purpose

The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.

Official Title

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Hematopoietic stem cell transplantation (HSCT) for any indication.
    1. * Patients will range from age 0 to age 21. There is no gender restriction. We expect the male to female ratio to end up being about 50/50* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
View All Criteria
Show Less

Investigator(s)

Rajni Agarwal-Hashmi
Professor of Pediatrics (Stem Cell Transplantation)

Contact us to find out if this trial is right for you.

Contact

Kimberly Boynton
650-498-6713

View on ClinicalTrials.gov